• Tue. Apr 28th, 2026

Fiscal

  • Home
  • Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update

Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update

Subsidiary, Citius Oncology, launches cancer immunotherapy, LYMPHIR™, in the U.S. in December 2025 CRANFORD, N.J., Dec. 23, 2025 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius Pharma” or the “Company”) (Nasdaq: CTXR),…

Ciena Reports Fiscal Fourth Quarter 2025 and Year-End Financial Results

Summary Fiscal fourth quarter 2025 revenue was $1.35 billion, up 20% year-over-year Fiscal year 2025 revenue was $4.77 billion, up 19% year-over-year Providing guidance for revenue in the range of…

Fiscal Committee Members Want to Better Track State’s Financial Health

By GARRY RAYNO, InDepthNH.org CONCORD — Several members of the Joint Legislative Fiscal Committee want to prevent the state from running a deficit two years in a row. Friday, Senate…

Workday Announces Fiscal 2026 Second Quarter Financial Results

Fiscal Second Quarter Total Revenues of $2.348 Billion, Up 12.6% Year-Over-Year Subscription Revenues of $2.169 Billion, Up 14.0% Year-Over-Year PLEASANTON, Calif., Aug. 21, 2025 /PRNewswire/ — Workday, Inc. (NASDAQ: WDAY),…

Medtronic reports first quarter fiscal 2026 financial results

11th quarter in a row of mid-single digit organic revenue growth; Poised to accelerate growth GALWAY, Ireland, Aug. 19, 2025 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in…

Fiscal watchdog says state financial oversight for CPS is worth exploring

With Chicago Public Schools grappling with a $529 million deficit and no clear way to balance its budget for the fall, the state might want to take over the school…